Summary
American tegumentary leishmaniasis is an endemic anthropozoonosis undergoing expansion on the American continent. The disease is caused by several Leishmania species, and, thus, there are intraspecific parasitological dissimilarities that may generate different pathologies. Furthermore, in America, Leishmania spp. has diverse reservoirs (that may change continuously) and can use various vectors to infect humans and mammals. Antimonials are the drugs of choice for the treatment of American tegumentary leishmaniasis; however, their efficacy is not predictable, and this may be linked to parasite drug resistance. This is further complicated by the fact that the etiological parasitic species in America belong to both the Leishmania and the Viannia subgeni. For all these reasons, the identification of the etiological infectious agent – up to the species level – is fundamental for precise clinical diagnosis, for treatment and prognosis, and for control of the disease. The present chapter offers a description of American tegumentary leishmaniasis, a fundamental piece of knowledge for the comprehension of the challenges we face for leishmaniasis in times of drug resistance. As a way to better understand the unique scenario that America offers for leishmaniasis, some data related to the figures present in the Old World will be presented.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akilov OE, Khachemoune A, Hasan T (2007) Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol 46:132–142
Barral A et al (1995) Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol 34:474–479
Bittencourt AL et al (1993) Leishmaniasis recidiva cutis in American cutaneous leishmaniasis. Int J Dermatol 32:802–805
Bray RS, Lainson R (1965) The immunology and serology of leishmaniasis the fluorescent antibody staining technique. Trans Roy Soc Trop Med Hyg 59:535–544
Calvopina M et al (2006) Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization. Int J Dermatol 45:116–120
Castés M, Tapia FJ (1998) Inmunopatologia de la leishmaniasis tegumentaria americana. Acta Cient Venezolana 49:42–56
Convit J (1996) Leishmaniasis immunological and clinical aspects and vaccines in Venezuela. Clin Dermatol 14:479–487
Convit J et al (1989) Inmunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis 160:104–115
Convit J et al (1993) The clinical and inmunological spectrum of American cutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg 87:444–448
Cuba CA et al (2000) Diagnóstico parasitológico e inmunológico de leishmaniasis tegumentaria Americana. Rev Med Exper 17:1–4
Davies CR et al (2000) The epidemiology and control of leishmaniasis in Andean countries. Cader Saude Publ 16:925–950
de Castro EA et al (2005) Eco-epidemiological survey of Leishmania (Viannia) braziliensis American cutaneous and mucocutaneous leishmaniasis in Ribeira Valley River, Parana State, Brazil. Acta Trop 93:141–149
De Lima H et al (2002) Cotton rats and black rats as possible reservoirs of cutaneous leishmaniasis in an endemic area in Lara State, Venezuela. Memór Instit Oswaldo Cruz 97:169–174
El-Hassan AM et al (1995) Sudanese mucocutaneous leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment. Trans Roy Soc Trop Med Hyg 89:647–652
Feliciangeli MD (1991) Vectors of leishmaniasis in Venezuela. Parassitologia 33:229–236
Feliciangeli MD, Rabinovich J (1998) Abundance of Lutzomyia ovallensi but not Lu. Gomezi (Diptera:Psychodidae) correlated with cutaneous leishmaniasis incidence in north-central Venezuela. Med Vet Entomol 12:121–131
Feliciangeli MD et al (1994) Vectors of cutaneous leishmaniasis in north-central Venezuela. Med Vet Entomol 8:317–324
Garcia AL et al (2009) Leishmaniases in Bolivia: comprehensive review and current status. Am J Trop Med Hyg 80:704–711
Gautret P et al (2009) Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe and for the GeoSentinel Surveillance Network. Emerg Infect Dis 15:1783–1790
Goto H, Lindoso JA (2010) Current diagnosis and treatment of cutaneous and mucocutaneous Leishmaniasis. Exp Rev Anti-infect Ther 8:419–433
Gramiccia M, Gradoni L (2005) The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol 35(11–12):1169–1180
Grimaldi G Jr, Tesh RB, McMahon-Pratt D (1989) A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 41:687–725
Jones TC et al (1987) Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 156:73–83
López M et al (1993) Diagnosis of Leishmanina using the polymerase chain reaction: a simplified procedure for field work. Am J Trop Med Hyg 49:34–42
Machado P et al (2002) Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis 34:E69–E73
Marsden PD (1986) Mucocutaneous leishmaniasis (“Espundia” Escomel, 1911). Trans Roy Soc Trop Med Hyg 80:859–876
Moll H (1997) The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis. Behring Inst Mitt 99:73–78
Moll H (2000) The role of dendritic cells at the early stages of Leishmania infection. Adv Exp Med Biol 479:163–173
Natera S et al (2007) Leishmania s.p.: proficiency of drug resistant parasites. Int J Antimicrob Agents 29:637–642
Oliveira-Neto MP et al (1998) Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 37:846–849
Padrón Nieves M et al (2008) Valor pronóstico de los cambios fisiológicos asociados a la quimio-resistencia en Leishmania. Vitae 33: http://vitae.ucv.ve/
Ponte-Sucre A (2003) Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy. Kinetoplastid Biol Dis 2:14 http://www.kinetoplastids.com/home/
Puig L, Pradinaud R (2003) Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol 97:107–114
Reed SG (1996) Diagnosis of leishmaniasis. Clin Dermatol 14:471–478
Reithinger R et al (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7:581–596
Restrepo IM (1980) La reacción de Montenegro en la epidemiología de la leishmaniasis sudamericana. Bol Oficina Sanit Panam 89:130
Ridley DS et al (1980) A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. Trans Roy Soc Trop Med Hyg 74:508
Rodríguez N et al (1994) Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J Clin Microbiol 32:2246–2252
Rondón A (1993) Leishmaniasis tegumentaria americana. Clin Dermatol Venezolana 31:12–17
Sanchez MA et al (1993) Epidermal Langerhans cells and dendritic epidermal T cells in murine cutaneos leishmaniasis. Immunocytochemical Study. Acta Microscop 2:180–187
Sassi A et al (1999) Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin Exp Immunol 116:127–132
Scarisbrick JJ et al (2006) Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis. Trav Med Infect Dis 4:14–21
Shaw JJ, Lainson R (1975) Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg 69:323–335
Souza AS et al (2010) Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis 10:209 http://www.biomedcentral.com/1471-2334/10/209
Stuart K et al (2008) Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 118:1301–1310
Tapia FJ et al (1994) Adhesion molecules in lesions of American cutaneous leishmaniasis. Exp Dermatol 3:17–22
Turetz ML et al (2002) Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 186:1829–1834
Ulrich M et al (1995) Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen specific T cell anergy. Clin Exp Immunol 100:54–58
Weigle KA et al (1987) Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 36:489–496
World Health Organization (2010) Control of the leishmaniasis. Technical report series, vol 949, Geneva, 2010
Yardley V et al (2006) American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility? J Infect Dis 194:1168–1175
Zijlstra EE et al (2003) Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3:87–98
Acknowledgments
The authors are grateful for the financial support received from the Coordination for Research, Faculty of Medicine, Universidad Central de Venezuela (UCV), and the Council for Scientific and Humanistic Research (CDCH), UCV. Likewise, they are grateful for the support conferred by the Alexander von Humboldt Foundation, Germany, to Alicia Ponte-Sucre.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Zerpa, O., Ponte-Sucre, A. (2013). American Tegumentary Leishmaniasis. In: Ponte-Sucre, A., Diaz, E., Padrón-Nieves, M. (eds) Drug Resistance in Leishmania Parasites. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1125-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1125-3_10
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0238-1
Online ISBN: 978-3-7091-1125-3
eBook Packages: MedicineMedicine (R0)